Astellas Pharma Inc (ALPMY)
9.47
-0.02
(-0.21%)
USD |
OTCM |
Apr 24, 16:00
Astellas Pharma Cash and Short Term Investments (Quarterly): 2.024B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.024B |
| September 30, 2023 | 2.434B |
| June 30, 2023 | 4.163B |
| March 31, 2023 | 2.977B |
| December 31, 2022 | 3.152B |
| September 30, 2022 | 2.720B |
| June 30, 2022 | 2.465B |
| March 31, 2022 | 2.763B |
| December 31, 2021 | 3.199B |
| September 30, 2021 | 2.933B |
| June 30, 2021 | 2.768B |
| March 31, 2021 | 3.007B |
| December 31, 2020 | 3.166B |
| September 30, 2020 | 2.786B |
| June 30, 2020 | 2.273B |
| March 31, 2020 | 3.034B |
| December 31, 2019 | 2.591B |
| September 30, 2019 | 3.069B |
| June 30, 2019 | 2.441B |
| March 31, 2019 | 2.829B |
| December 31, 2018 | 3.200B |
| September 30, 2018 | 2.950B |
| June 30, 2018 | 3.017B |
| March 31, 2018 | 3.249B |
| December 31, 2017 | 3.488B |
| Date | Value |
|---|---|
| September 30, 2017 | 3.159B |
| June 30, 2017 | 3.093B |
| March 31, 2017 | 3.170B |
| December 31, 2016 | 3.193B |
| September 30, 2016 | 3.737B |
| June 30, 2016 | 3.158B |
| March 31, 2016 | 3.331B |
| December 31, 2015 | 3.006B |
| September 30, 2015 | 3.478B |
| June 30, 2015 | 3.388B |
| March 31, 2015 | 3.802B |
| December 31, 2014 | 3.981B |
| September 30, 2014 | 4.236B |
| June 30, 2014 | 4.006B |
| March 31, 2014 | 4.147B |
| December 31, 2013 | 3.524B |
| September 30, 2013 | 3.556B |
| June 30, 2013 | 3.252B |
| March 31, 2013 | 3.354B |
| December 31, 2012 | 3.298B |
| September 30, 2012 | 3.318B |
| June 30, 2012 | 3.282B |
| March 31, 2012 | 3.660B |
| December 31, 2011 | 3.622B |
| September 30, 2011 | 3.673B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.024B
Minimum
Dec 2023
4.163B
Maximum
Jun 2023
2.840B
Average
2.786B
Median
Sep 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 2.251B |
| Nxera Pharma Co Ltd | 350.16M |
| PeptiDream Inc | 138.37M |
| Stemcell Holdings Inc | 5.116M |
| Healios KK | 47.67M |